Cramer Pamela J. sold RYTM
July 9, 2025 · Form 4 insider transaction
Cramer Pamela J. sold 3,516 shares of Rhythm Pharmaceuticals, Inc. at $80.00 per share, a transaction worth $281.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,516
Price
$80.00
Total value
$281.3K
InsiderCramer Pamela J.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 9, 2025
Filing dateJuly 11, 2025
Shares owned after19,209
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.